Shuai Wu Selected Research

Shuai Wu Research Topics

Disease

33	Neoplasms (Cancer) 10/2022 - 01/2009
9	Inflammation (Inflammations) 01/2022 - 01/2017
6	Glioma (Gliomas) 10/2021 - 01/2019
5	Colitis 01/2022 - 06/2018
5	Carcinoma (Carcinomatosis) 01/2021 - 05/2015
5	Urinary Bladder Neoplasms (Bladder Cancer) 03/2017 - 01/2009
4	Stomach Neoplasms (Stomach Cancer) 01/2022 - 09/2013
4	Carcinogenesis 01/2022 - 01/2015
4	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 01/2018
3	Uveal melanoma 01/2022 - 11/2019
3	Colonic Neoplasms (Colon Cancer) 10/2021 - 01/2013
3	Chronic Hepatitis B 06/2021 - 09/2014
3	Stroke (Strokes) 07/2019 - 09/2015
3	Infections 01/2019 - 03/2012
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 05/2015 - 07/2012
2	Retinoblastoma (Glioblastoma, Retinal) 02/2022 - 11/2020
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 05/2020
2	Huntington Disease (Huntington's Disease) 01/2022 - 01/2015
2	Hepatitis B 06/2021 - 09/2014
2	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2021
2	Ovarian Epithelial Carcinoma 10/2020 - 01/2019
2	Fibrosis (Cirrhosis) 04/2020 - 06/2013
2	Hypoxia (Hypoxemia) 01/2020 - 06/2013
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2018 - 09/2015
2	Ulcerative Colitis 01/2018 - 01/2018
2	Ischemic Stroke 02/2016 - 09/2015
2	Multiple Sclerosis 05/2015 - 07/2012
1	Burns 01/2022
1	Ischemia 01/2022
1	Spinal Cord Ischemia 01/2022
1	Malignant Mesothelioma 01/2022
1	Colitis-Associated Neoplasms 01/2022
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2022
1	Wounds and Injuries (Trauma) 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Reperfusion Injury 01/2022
1	Hyperplasia 11/2021
1	Vomiting 08/2021
1	Rectal Neoplasms (Rectal Cancer) 08/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Pressure Ulcer (Bedsore) 01/2021
1	Chemotherapy-Related Cognitive Impairment 01/2021
1	Staphylococcal Infections 01/2021
1	Skin Neoplasms (Skin Cancer) 01/2021

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 03/2022 - 01/2016
6	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2015
5	Long Noncoding RNAIBA 10/2021 - 01/2018
4	InterferonsIBA 06/2021 - 09/2014
4	Immune Checkpoint InhibitorsIBA 01/2021 - 11/2019
3	Biological ProductsIBA 03/2022 - 01/2019
3	DNA (Deoxyribonucleic Acid)IBA 06/2021 - 06/2019
3	Pharmaceutical PreparationsIBA 01/2021 - 01/2015
3	Metal-Organic FrameworksIBA 01/2020 - 01/2019
3	CytokinesIBA 10/2018 - 07/2012
3	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2015 - 06/2013
2	AntigensIBA 03/2022 - 06/2021
2	CateninsIBA 01/2022 - 01/2020
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 10/2021 - 06/2021
2	Antiviral Agents (Antivirals)IBA 06/2021 - 01/2019
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 06/2021 - 04/2020
2	coactivator-associated arginine methyltransferase 1IBA 01/2021 - 12/2018
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2020 - 01/2019
2	Phosphotransferases (Kinase)IBA 01/2020 - 06/2018
2	NAD (NADH)IBA 01/2020 - 01/2017
2	Mitogen-Activated Protein KinasesIBA 06/2018 - 09/2013
2	ChromatinIBA 01/2018 - 01/2017
2	Histone Deacetylase InhibitorsIBA 01/2018 - 01/2018
2	Clopidogrel (Plavix)FDA Link 02/2016 - 09/2015
1	lupeolIBA 02/2022
1	TOR Serine-Threonine KinasesIBA 02/2022
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 02/2022
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 02/2022
1	tanshinoneIBA 01/2022
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	plerixafor FDA Link 01/2022
1	CXCR4 Receptors (CXCR4 Receptor)IBA 01/2022
1	salicylhydroxamic acid (SHAM)IBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2021
1	Tropisetron (Navoban)IBA 08/2021
1	Temozolomide (Temodar)FDA LinkGeneric 03/2021
1	Indicators and Reagents (Reagents)IBA 03/2021
1	Hematoxylin (Haematoxylon)IBA 01/2021
1	Propylene Glycol (1,2 Propanediol)FDA LinkGeneric 01/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2021
1	gambogic acidIBA 01/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	GlutaminaseIBA 01/2021
1	Glutamine (L-Glutamine)FDA Link 01/2021
1	Antimicrobial PeptidesIBA 01/2021
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2021

Therapy/Procedure

22	Therapeutics 10/2022 - 01/2009
3	Drug Therapy (Chemotherapy) 08/2021 - 01/2021
3	Fecal Microbiota Transplantation 01/2020 - 11/2017
2	Radiotherapy 01/2022 - 03/2021
2	Cystectomy 01/2015 - 01/2009
1	Precision Medicine 03/2022
1	Intravenous Injections 01/2021
1	Adjuvant Chemotherapy 01/2021
1	Topical Administration 01/2021